TransMedics Group, Inc. (TMDX)
91.37
-0.63
(-0.68%)
USD |
NASDAQ |
Nov 13, 16:00
90.10
-1.27
(-1.39%)
After-Hours: 19:59
TransMedics Group Shareholders Equity (Quarterly) : 550.71M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 550.71M |
| June 30, 2026 | 518.05M |
| March 31, 2026 | 494.01M |
| December 31, 2025 | 473.10M |
| September 30, 2025 | 355.20M |
| June 30, 2025 | 318.10M |
| March 31, 2025 | 266.31M |
| December 31, 2024 | 228.60M |
| September 30, 2024 | 209.92M |
| June 30, 2024 | 189.89M |
| March 31, 2024 | 159.47M |
| December 31, 2023 | 137.20M |
| September 30, 2023 | 126.46M |
| June 30, 2023 | 145.21M |
| March 31, 2023 | 192.62M |
| December 31, 2022 | 187.38M |
| September 30, 2022 | 187.86M |
| June 30, 2022 | 50.92M |
| Date | Value |
|---|---|
| March 31, 2022 | 59.91M |
| December 31, 2021 | 67.85M |
| September 30, 2021 | 78.55M |
| June 30, 2021 | 88.98M |
| March 31, 2021 | 97.68M |
| December 31, 2020 | 103.89M |
| September 30, 2020 | 109.55M |
| June 30, 2020 | 113.76M |
| March 31, 2020 | 46.68M |
| December 31, 2019 | 54.65M |
| September 30, 2019 | 63.47M |
| June 30, 2019 | 71.16M |
| March 31, 2019 | -12.52M |
| December 31, 2018 | -5.723M |
| September 30, 2018 | 1.822M |
| June 30, 2018 | 6.86M |
| March 31, 2018 | |
| December 31, 2017 | 17.80M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp. | 25.63B |
| Insulet Corp. | 1.579B |
| Abbott Laboratories | 51.03B |
| Baxter International, Inc. | 6.502B |
| Becton, Dickinson & Co. | 24.68B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.518B |
| Total Liabilities (Quarterly) | 967.22M |
| Debt to Equity Ratio | 1.574 |
| Current Ratio | 4.530 |
| Net Debt Paydown Yield | -2.40% |